Stockscreener 앱 받기
14.06
2.56%
-0.37
전일 마감가:
$14.43
열려 있는:
$14.27
하루 거래량:
95,324
Relative Volume:
0.41
시가총액:
$411.58M
수익:
$30.43M
순이익/손실:
$-18.15M
주가수익비율:
-20.38
EPS:
-0.69
순현금흐름:
$-9.08M
1주 성능:
-4.42%
1개월 성능:
+27.47%
6개월 성능:
+9.67%
1년 성능:
+139.52%
1일 변동 폭
$13.95
$14.35
1주일 범위
$13.90
$14.95
52주 변동 폭
$5.11
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
CLPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
14.05 | 411.58M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
132.26 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.55 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.49 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.41 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.32 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
(CLPT) Technical Data - news.stocktradersdaily.com
After Leaping 31% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - simplywall.st
ClearPoint Neuro (CLPT) Expands Use of Prism Neuro Laser with FD - GuruFocus
ClearPoint Neuro: Fundamentals Continue To Strengthen - Seeking Alpha
ClearPoint Neuro, Together with its Partner Clinical Laserthermi - GuruFocus
ClearPoint Neuro expands FDA application for MRI system - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
ClearPoint Neuro FDA Filing Could Double Market Access for Laser Therapy System | CLPT Stock News - Stock Titan
Invesco Ltd. Purchases Shares of 247,977 ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance - TradingView
Geode Capital Management LLC Has $4.37 Million Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing - Yahoo Finance
ClearPoint Neuro Inc (CLPT) Shares Up 7.42% on Apr 25 - GuruFocus
B. Riley Adjusts Price Target on ClearPoint Neuro to $28 From $20, Maintains Buy Rating - marketscreener.com
B. Riley Boosts ClearPoint Neuro (CLPT) Price Target, Affirms Bu - GuruFocus
Lake Street Sticks to Its Buy Rating for ClearPoint Neuro (CLPT) - The Globe and Mail
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 | CLPT Stock News - GuruFocus
ClearPoint Neuro Earnings: Brain Navigation Tech Leader Sets Q1 2025 Financial Review - Stock Titan
Shareholders have faith in loss-making ClearPoint Neuro (NASDAQ:CLPT) as stock climbs 17% in past week, taking five-year gain to 280% - simplywall.st
ClearPoint Neuro Announces Full Market Release of ClearPoint Nav - GuruFocus
ClearPoint Neuro (CLPT) Launches Enhanced Navigation Software to Improve OR Accessibility | CLPT Stock News - GuruFocus
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 -- Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room | CLPT Stock News - GuruFocus
Game-Changing Surgical Navigation Software Eliminates MRI Requirement in Operating Rooms - Stock Titan
LPL Financial LLC Buys 1,750 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
How to Take Advantage of moves in (CLPT) - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 5,400 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Head to Head Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. Avinger (NASDAQ:AVGR) - Defense World
Financial Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. enVVeno Medical (NASDAQ:NVNO) - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Given New $25.00 Price Target at Stifel Nicolaus - Defense World
Stifel raises Clearpoint Neuro stock target to $25 on growth potential - Investing.com Canada
Here's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn Situation - Yahoo
Both individual investors who control a good portion of ClearPoint Neuro, Inc. (NASDAQ:CLPT) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
ClearPoint Neuro Inc (CLPT) Shares Gap Down to $13.235 on Mar 25 - GuruFocus.com
When (CLPT) Moves Investors should Listen - news.stocktradersdaily.com
Connor Clark & Lunn Investment Management Ltd. Reduces Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Tuesday - Defense World
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results - ACCESS Newswire
How To Trade (CLPT) - Stock Traders Daily
What is B. Riley’s Forecast for CLPT FY2025 Earnings? - Defense World
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Taylor Frigon Capital Management LLC Sells 162,551 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen - Seeking Alpha
ClearPoint Neuro’s Earnings Call Highlights Robust Growth - TipRanks
MRI Interventions, Inc. Announces 2016 Third Quarter and Nine Month Results - ACCESS Newswire
ClearPoint Neuro (NASDAQ:CLPT) Issues Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates - MSN
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2024 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro Achieves Record Growth in 2024 - TipRanks
Clearpoint Neuro Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: ClearPoint Neuro Q4 2024 sees stock dip post-earnings - Investing.com India
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.11%
0.14%
자본화:
|
볼륨(24시간):